BibTex RIS Cite

Emergency Department Physicians’ Knowledge of Synthetic Cannabinoids

Year 2015, Volume: 22 Issue: 4, 249 - 252, 14.12.2015

Abstract

Aim: Substances containing synthetic cannabinoid are known with different names in various countries and abuse of these substances increase day by day. Different combinations of these substances make difficult to predict clinical effects. In this study, the aim is to evaluate the awareness of emergency department physicians on the clinical presentation of people using these substances.

Materials and Methods: A questionnaire was applied to 100 physicians in emergency departments; the survey did not involve any scales but only contained the following three options: “Yes,” “No,” and “No idea.”

Results: The average age of physicians was 34,5±6,8 and the average work experience in the emergency department was 6,4±5,2 years. The proportion of research assistants was 42%; 29% of the physicians were experts while the other 29% were practitioners. The rate of the physicians with true knowledge abouth varied clinical appearances of drug abuse was 68%. The percentage of physicians who had no idea about the variable contents of this substances was 44%. 80% of the physicians knew that it is necessary to report these cases as "Criminal cases."

Conclusion: Due to the rapid increase in the use of substances containing synthetic cannabinoid, physicians should consider welcoming new information and improve their knowledge on these substances and their properties.

Keywords: Substance Dependence; Hospital Emergency Service; Legal Medicine.

References

  • Journal of Psychiatry and Neurological Sciences 2013;26:1-11.
  • Harris CR, Brown A. Synthetıc cannabınoıd ıntoxıcatıon: A case serıes and revıew. The Journal of Emergency Medıcıne 2013;44(2):360-6.
  • Hudson S, Ramsey J, King L, Timbers S, Maynard S, Dragan PI et al. Use of high resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in ‘herbal high’ products. J Anal Toxicol 2012;120:238-41.
  • Lank PM, Pines E, Mycyk MB. Emergency physicians’ knowledge of cannabinoid designer drugs. Western Journal of Emergency Medicine 2013; XIV:5: 467-70.
  • Sun X, Dey SK. Synthetıc cannabınoıds and potentıal reproductıve consequences. Life Sciences 2014;97:72-7.
  • Vardakou I, Pistos C, Spiliopoulou CH. Spice drugs as a new trend: Mode of actıon, ıdentıfıcatıon and legıslatıon. Toxicol Lett 2010;197:157-62.
  • Vandrey R, Dunn KE, Fry JA, Girling ER. A survey study to characterize use of spice products (synthetic cannabinoids). Drug and Alcohol Dependence 2012;120:238-41.
  • Schneir AB, Cullen J, Ly BT. ‘Spice’ girls: Synthetic cannabinoid intoxication. J Emerg Med 2011;40:296-9.
  • Kamijo Y, Michiko T, Fujita Y, Hirose Y, Iwasaki Y, Ishihara S et al. A multicenter retrospective survey of poisoning after consumption of products containing synthetic chemicals in Japan. Intern Med 2014;53:2439-45.
  • Corazza O, Assi S, Schifano F. From ‘special K’ to ‘special M’:the evolution of the recreational use of ketamine and methoxetamine. CNS Neurosci Ther 2013;19:454-60.
  • Wood DM, Davies S, Puchnarewicz M, Johnstone A, Dargan PI. Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine. Eur J Clin Pharmacol 2012;68:853-6.
  • Bozkurt M, Umut G, Evren C, Karabulut V. Sentetik kannabinoid kullanımı nedeniyle polikliniğe başvuran hastaların klinik özellikleri ve laboratuvar sonuçları. Düşünen Adam The Journal of Psychiatry and Neurological Sciences 2014;27:328-34.
  • Winstock AR, Barratt M. The 12 month prevalence and nature of adverse experiences resulting in emergency medical presentation with the use of synthetc cannabinoid product. Hum. Psychopharmacol Clin Exp 2013;28:390-3.
  • Forrester MB, Kleinschmidt K, Schwarz E, Young A. Synthetic cannabinoid exposures reported to Texas poison centers. J Addict Dis 2011;30:351-8.
  • Forrester MB. Adolescent synthetic cannabinoid exposures reported to Texas poison centers. Pediatr Emerg Care 2012;28:985-9.
  • Cohen J, Morrison S, Greenberg J, Saidinejad M. Clinical presentation of intoxication due to synthetic cannabinoids. Pediatrics 2012;129:1064-7.
  • Yalvaç G. Karşılaştırmalı –Gerekçeli TCK CMK CGTİK ve İlgili Kanunlar ile Yönetmelikler. 1. Baskı. Ankara. Adalet Yayınevi; 2005. p.450.
  • Tuğcu H. Acil olgularda hekim sorumluluğu. Klinik Gelişim Dergisi Adli Tıp Özel Sayısı 2009;22:85-8.
  • Zeyfeoğlu Y. Acil hekiminin hukuki yükümlülükleri. Türkiye Klinikleri Cerrahi Tıp Bilimleri 2006;2:10-9.

Journal of Turgut Ozal Medical Center

Year 2015, Volume: 22 Issue: 4, 249 - 252, 14.12.2015

Abstract

Amaç: İçerisinde sentetik kannabinoid bulunan maddeler çeşitli ülkelerde değişik adlarla bilinmekte ve bu maddelerin kötüye kullanımı giderek artmaktadır. Farklı kombinasyonlar klinik etkilerin tahmin edilmesini güçleştirmektedir. Çalışmada, acil servis hekimlerinin, bu maddeleri kullananlardaki klinik görünüm hakkında seçilen konularla ilgili farkındalığını değerlendirmek amaçlanmıştır. Gereç ve Yöntemler: Acil servislerde çalışan 100 hekime konu ile ilgili olarak hazırlanmış, herhangi bir ölçek içermeyen, ‘evet’ ‘hayır’ ve ‘fikrim yok’ cevaplarını içeren anket uygulandı. Bulgular: Hekimlerin yaş ortalaması 34,5±6,8, acil servisteki çalışma yılı ortalamaları 6,4±5,2 yıl olarak tespit edilmiştir. Araştırma görevlilerinin oranı %42, uzmanların %29, pratisyenlerin oranı da %29’dur. Hekimlerin klinik görünümün değişkenlik gösterdiğini doğru bilme oranı %68’dir. İçeriklerinin değişken olduğu konusunda fikri olmayan hekim oranı %44’tür olup “Adli vaka” olarak bildirmenin gerekli olduğunu %80 hekim bilmektedir. Tartışma: Sentetik kannabinoid içeren maddelerin kullanımında görülen hızlı artış nedeniyle hekimlerin bu maddeler ve özellikleri konusunda bilgilerinin arttırılması gerektiği düşünülmektedir

References

  • Journal of Psychiatry and Neurological Sciences 2013;26:1-11.
  • Harris CR, Brown A. Synthetıc cannabınoıd ıntoxıcatıon: A case serıes and revıew. The Journal of Emergency Medıcıne 2013;44(2):360-6.
  • Hudson S, Ramsey J, King L, Timbers S, Maynard S, Dragan PI et al. Use of high resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in ‘herbal high’ products. J Anal Toxicol 2012;120:238-41.
  • Lank PM, Pines E, Mycyk MB. Emergency physicians’ knowledge of cannabinoid designer drugs. Western Journal of Emergency Medicine 2013; XIV:5: 467-70.
  • Sun X, Dey SK. Synthetıc cannabınoıds and potentıal reproductıve consequences. Life Sciences 2014;97:72-7.
  • Vardakou I, Pistos C, Spiliopoulou CH. Spice drugs as a new trend: Mode of actıon, ıdentıfıcatıon and legıslatıon. Toxicol Lett 2010;197:157-62.
  • Vandrey R, Dunn KE, Fry JA, Girling ER. A survey study to characterize use of spice products (synthetic cannabinoids). Drug and Alcohol Dependence 2012;120:238-41.
  • Schneir AB, Cullen J, Ly BT. ‘Spice’ girls: Synthetic cannabinoid intoxication. J Emerg Med 2011;40:296-9.
  • Kamijo Y, Michiko T, Fujita Y, Hirose Y, Iwasaki Y, Ishihara S et al. A multicenter retrospective survey of poisoning after consumption of products containing synthetic chemicals in Japan. Intern Med 2014;53:2439-45.
  • Corazza O, Assi S, Schifano F. From ‘special K’ to ‘special M’:the evolution of the recreational use of ketamine and methoxetamine. CNS Neurosci Ther 2013;19:454-60.
  • Wood DM, Davies S, Puchnarewicz M, Johnstone A, Dargan PI. Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine. Eur J Clin Pharmacol 2012;68:853-6.
  • Bozkurt M, Umut G, Evren C, Karabulut V. Sentetik kannabinoid kullanımı nedeniyle polikliniğe başvuran hastaların klinik özellikleri ve laboratuvar sonuçları. Düşünen Adam The Journal of Psychiatry and Neurological Sciences 2014;27:328-34.
  • Winstock AR, Barratt M. The 12 month prevalence and nature of adverse experiences resulting in emergency medical presentation with the use of synthetc cannabinoid product. Hum. Psychopharmacol Clin Exp 2013;28:390-3.
  • Forrester MB, Kleinschmidt K, Schwarz E, Young A. Synthetic cannabinoid exposures reported to Texas poison centers. J Addict Dis 2011;30:351-8.
  • Forrester MB. Adolescent synthetic cannabinoid exposures reported to Texas poison centers. Pediatr Emerg Care 2012;28:985-9.
  • Cohen J, Morrison S, Greenberg J, Saidinejad M. Clinical presentation of intoxication due to synthetic cannabinoids. Pediatrics 2012;129:1064-7.
  • Yalvaç G. Karşılaştırmalı –Gerekçeli TCK CMK CGTİK ve İlgili Kanunlar ile Yönetmelikler. 1. Baskı. Ankara. Adalet Yayınevi; 2005. p.450.
  • Tuğcu H. Acil olgularda hekim sorumluluğu. Klinik Gelişim Dergisi Adli Tıp Özel Sayısı 2009;22:85-8.
  • Zeyfeoğlu Y. Acil hekiminin hukuki yükümlülükleri. Türkiye Klinikleri Cerrahi Tıp Bilimleri 2006;2:10-9.
There are 19 citations in total.

Details

Primary Language Tr
Journal Section Articles
Authors

Beyza Urazel This is me

Aslıhan Teyin This is me

Şeyhmus Kaya This is me

Ümit Şimşek This is me

Tarık Gündüz This is me

Publication Date December 14, 2015
Published in Issue Year 2015 Volume: 22 Issue: 4

Cite

APA Urazel, B., Teyin, A., Kaya, Ş., Şimşek, Ü., et al. (2015). Emergency Department Physicians’ Knowledge of Synthetic Cannabinoids. Journal of Turgut Ozal Medical Center, 22(4), 249-252.
AMA Urazel B, Teyin A, Kaya Ş, Şimşek Ü, Gündüz T. Emergency Department Physicians’ Knowledge of Synthetic Cannabinoids. J Turgut Ozal Med Cent. December 2015;22(4):249-252.
Chicago Urazel, Beyza, Aslıhan Teyin, Şeyhmus Kaya, Ümit Şimşek, and Tarık Gündüz. “Emergency Department Physicians’ Knowledge of Synthetic Cannabinoids”. Journal of Turgut Ozal Medical Center 22, no. 4 (December 2015): 249-52.
EndNote Urazel B, Teyin A, Kaya Ş, Şimşek Ü, Gündüz T (December 1, 2015) Emergency Department Physicians’ Knowledge of Synthetic Cannabinoids. Journal of Turgut Ozal Medical Center 22 4 249–252.
IEEE B. Urazel, A. Teyin, Ş. Kaya, Ü. Şimşek, and T. Gündüz, “Emergency Department Physicians’ Knowledge of Synthetic Cannabinoids”, J Turgut Ozal Med Cent, vol. 22, no. 4, pp. 249–252, 2015.
ISNAD Urazel, Beyza et al. “Emergency Department Physicians’ Knowledge of Synthetic Cannabinoids”. Journal of Turgut Ozal Medical Center 22/4 (December 2015), 249-252.
JAMA Urazel B, Teyin A, Kaya Ş, Şimşek Ü, Gündüz T. Emergency Department Physicians’ Knowledge of Synthetic Cannabinoids. J Turgut Ozal Med Cent. 2015;22:249–252.
MLA Urazel, Beyza et al. “Emergency Department Physicians’ Knowledge of Synthetic Cannabinoids”. Journal of Turgut Ozal Medical Center, vol. 22, no. 4, 2015, pp. 249-52.
Vancouver Urazel B, Teyin A, Kaya Ş, Şimşek Ü, Gündüz T. Emergency Department Physicians’ Knowledge of Synthetic Cannabinoids. J Turgut Ozal Med Cent. 2015;22(4):249-52.